Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed stock exchanges about an upcoming virtual meeting with Franklin Templeton Mutual Fund, scheduled for Monday, June 16, 2025. The interaction is classified as an institutional investor meeting and is being conducted under SEBI's Listing Obligations and Disclosure Requirements rules. The company has clarified that only publicly available information will be discussed, and no unpublished price-sensitive information (UPSI) will be shared. This is a routine compliance intimation, with the schedule being indicative and subject to change.
This is a standard regulatory disclosure with no material business or financial impact. Such meetings are common and typically do not move the stock price unless accompanied by new information or strategic updates.